Markets are trying hard to see the bright side of bad news in the United States, anticipating dour data will trigger the ...

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...

Pfizer's strong EPS surprise streak and positive earnings revisions are encouraging, but patent cliff risks remain a major ...

The third ultra-high-yield dividend stock that makes for a no-brainer buy in August is none other than the premier retail ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pfizer Inc. (NYSE:PFE) will release earnings results for the second quarter before the opening bell on Tuesday, Aug. 5.

Pfizer Inc. (NYSE:PFE) reported in its fiscal Q1 2025 results that the first phase of its manufacturing optimization program ...

Estimate trends have been broadly positive heading into the print: EPS estimates have seen 7 upward revisions and 3 downward over the past 90 days. Revenue estimates have been revised upward 8 times, ...

The market's not seeing its future in quite the right light, though. Are you looking to put a sizable chunk of cash to work ...

The data-software company's stock rose 5% premarket after it posted higher quarterly profit and revenue. It also [boosted its annual outlook]( ...

The drug maker reports second-quarter earnings Tuesday, and investors continue to eye a list of glaring problems.